A1 Refereed original research article in a scientific journal
Intellectual disability in patients with epilepsy with eyelid myoclonias
Authors: Maria Arvio, Oili Sauna-aho, Timo Nyrke, Nina Bjelogrlic-Laakso
Publisher: SAGE PUBLICATIONS INC
Publication year: 2018
Journal: SAGE Open Medical Case Reports
Journal name in source: SAGE OPEN MEDICAL CASE REPORTS
Journal acronym: SAGE OPEN MED CASE R
Volume: 6
Number of pages: 4
ISSN: 2050-313X
eISSN: 2050-313X
DOI: https://doi.org/10.1177/2050313X18777951
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/35920423
We describe here the clinical outcome of four women with epilepsy with eyelid myoclonia (aged 21-53years). All patients had an uneventful early history, normal physical growth and appearance and no comorbid sensory or motor disability and normal brain magnetic resonance imaging finding. Two women were moderately and one mildly intellectually disabled and one showed a low-average intelligence. The overall well-being of the patients was hampered by psychiatric or various somatic comorbidities and related psychosocial problems. The three women with an intellectual disability had been treated with narrow-spectrum antiepileptic drugs and one also with vigabatrin during childhood and adolescence. The patient with a low-average intelligence had been on broad-spectrum antiepileptic medication (i.e. valproate and ethosuximide) since the epilepsy diagnosis but she has had compliance problems. Based on these cases, the cognitive deficits in patients with epilepsy with eyelid myoclonia may occur more commonly than what has been thought hitherto. We discuss the role of narrow-spectrum antiepileptic drugs as a contributing factor to poor seizure control and an impaired intelligence.
Downloadable publication This is an electronic reprint of the original article. |  |
